drugset

drugset / Trial / NCT07382843

Melatonin Agonist for Shift-time Workers.

NCT07382843 ↗

Phase 4 Completed 61 enrolled Tri-Service General Hospital (TSGH)

NaSingle-groupOpen-labelTreatment

Summary

The study of the relationship between sleep pattern, attention performance, and heart rate variability among night workers.

Timeline

Start: 2024-03-04
Primary completion: 2025-12-31
Completion: 2025-12-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ramelteon	Unknown	8 mg	—

Indications